Vascular Therapies Overview

  • Founded
  • 2001

Founded
  • Status
  • Private

  • Employees
  • 8

Employees
  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $27.7M

  • Investors
  • 6

Vascular Therapies General Information

Description

Developer of a biotech firm designed to address major unmet clinical needs of patients requiring an AV fistula for dialysis. The company's therapies are used to offer biodegradable collagen implants to treat the problem of vascular anastomosis failure, enabling physicians to improve the outcomes of an Arteriovenous Fistula (AFV) and improve patients' lives.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Primary Office
  • 105 Union Avenue
  • Cresskill, NJ 07626
  • United States
+1 (201) 000-0000

Vascular Therapies Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vascular Therapies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 04-Mar-2022 $27.7M 00000 Completed Clinical Trials - Phase 3
9. Later Stage VC 28-Jan-2020 000.00 000.00 Completed Clinical Trials - Phase 3
8. Later Stage VC (Series E2) 10-Oct-2018 000.00 000.00 00000 Completed Clinical Trials - Phase 3
7. Later Stage VC (Series E) 14-Dec-2016 0000 000.00 00000 Completed Clinical Trials - Phase 3
6. Later Stage VC (Series D) 12-Jul-2013 000.00 000.00 000.00 Completed Clinical Trials - Phase 3
5. Later Stage VC 01-Dec-2012 0000 Completed Clinical Trials - Phase 3
4. Seed Round 22-Apr-2011 00.000 0000 Completed Clinical Trials - Phase 3
3. Grant 01-Jan-2009 00000 00.000 Completed Startup
2. Angel (individual) 17-Oct-2005 $7.49M $7.49M Completed Startup
1. Grant 01-Jan-2003 $125K Completed Startup
To view Vascular Therapies’s complete valuation and funding history, request access »

Vascular Therapies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E2 0,000,000 00.000000 00 00 00 00 00 0.000
Series E1 0,000,000 00.000000 00 00 00 00 00 00.000
Series D 0,000,000 00.000000 00 00 00 00 00 00.000
Series C2 0,000,000 00.000000 00 00 00 00 00 00.000
Series C1 0,000,000 00.000000 00 00.00 00.00 00 00 0.000
Series B4 00,000 00.000000 00 00 00 00 00 0.000
Series B3 000,000 00.000000 00 00 00 00 00 0.000
Series B2 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.00
Series B1 169,000 $0.001000 8% $0.01 $0.01 1x $0.01 0.05%
Series A4 316,667 $0.001000 8% $3 $3 1x $3 0.99%
To view Vascular Therapies’s complete cap table history, request access »

Vascular Therapies Patents

Vascular Therapies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20140088681-A1 Device and method for preventing stenosis at an anastomosis site Abandoned 27-Jan-2010 000000000 00
JP-2013517906-A Apparatus and method for prevention of stenosis at the site of anastomosis Granted 27-Jan-2010 000000000 00
JP-2018020104-A Device and method for preventing stenosis at anastomosis site Granted 27-Jan-2010 000000000 0
JP-2019150584-A Device and method for preventing constriction at anastomotic site Pending 27-Jan-2010 000000000
US-20170020651-A1 Device and method for preventing stenosis at an anastomosis site Abandoned 27-Jan-2010 A61F2/064 0
To view Vascular Therapies’s complete patent history, request access »

Vascular Therapies Executive Team (7)

Name Title Board Seat Contact Info
John McDermott Chief Executive Officer & Board Member
Sriram Iyer MD Founder, Chief Scientific Officer & Board Member
Paul Barkofsky Ph.D Vice President, New Product Development
Rosanne Terraciano Vice President, Operations
Maureen Harrison Vice President, Quality Assurance
You’re viewing 5 of 7 executive team members. Get the full list »

Vascular Therapies Board Members (11)

Name Representing Role Since
Allan Tessler Self Board Member 000 0000
Andrew Midler Savitr Capital Board Member 000 0000
Daniel Ryan The Spring Bay Companies Board Member 000 0000
Gerald Dorros MD The Gerrald Dorros and Myra S. Dorros Recovable Trust Board Member 000 0000
John McDermott Vascular Therapies Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Vascular Therapies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vascular Therapies Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Wexford Capital Asset Manager Minority 000 0000 000000 0
CNF Investments PE/Buyout Minority 000 0000 000000 0
The Spring Bay Companies Venture Capital Minority 000 0000 000000 0
Qualifying Therapeutic Discovery Project Government 000 0000 000000 0
The Gerrald Dorros and Myra S. Dorros Recovable Trust Other Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »